Home / Media Releases

Media Releases

Stay up to date with CannaPacific

e3D Pharma with the University of New South Wales to research cannabinoid actives for PTSD and Anxiety treatments using translational behavioural models.

e3D Pharma with the University of New South Wales to research cannabinoid actives for PTSD and Anxiety treatments using translational behavioural models. You can download this article as .pdf Media Release – e3D Pharma with the University of New South Wales to research cannabinoid actives for PTSD and Anxiety treatments using translational behavioural models. e3D

Novel pain signalling assays for the development of cannabinoid-based medicines

Novel pain signalling assays for the development of cannabinoid-based medicines You can download this article as .pdf pdf icon copy Novel pain signalling assays for the development of cannabinoid-based medicines Oval Partnership applies cutting edge assays to understand the mechanisms behind active components of cannabis and their effects on pain. NEWCASTLE, AUSTRALIA – Friday, 18

CannaPacific and CSIRO trial novel encapsulation technologies for medicinal cannabinoids

CannaPacific and CSIRO trial novel encapsulation technologies for medicinal cannabinoids You can download this article as .pdf pdf icon copy CannaPacific and CSIRO trial novel encapsulation technologies for medicinal cannabinoids Oval Australian biotechnology company CannaPacific today announced they are working in partnership with the CSIRO to trial novel encapsulation technologies for medicinal cannabinoids. Oval Improved

CannaPacific Awarded Permits for Cultivation, Production and Research of Medicinal Cannabis

CannaPacific Awarded Permits for Cultivation, Production and Research of Medicinal Cannabis You can download this article as .pdf pdf icon copy CannaPacific Awarded Permits for Cultivation, Production and Research of Medicinal Cannabis Oval Biotech company CannaPacific has been awarded cultivation, production and research permits from the Office of Drug Control Oval Byron Bay Hinterland Glasshouse

CannaPacific Collaborates with Greening Australia for Bushfire Regeneration

CannaPacific Collaborates with Greening Australia for Bushfire Regeneration You can download this article as .pdf pdf icon copy CannaPacific Collaborates with Greening Australia for Bushfire Regeneration LISMORE, AUSTRALIA – 15 October 2020 – Lismore-based CannaPacific, a biopharmaceutical company focused on medicinal cannabis, announced today an initiative to grow and donate 60,000 tube stock native plants

First Australian Export of Cannabis Product to South Africa

First Australian Export of Cannabis Product to South Africa You can download this article as .pdf pdf icon copy Media Release – First Australian Export of Cannabis Product to South Africa NEWCASTLE, AUSTRALIA – Tuesday 22 September 2020 – CannaPacific, an Australian biotechnology company focused on the cannabinoid pharmaceutical sector and Health House International have

Partners

We are proud to work with our partners to deliver one of the most advanced cannabis genomic breeding programs in the world 

Bitmap
tasmanian alkaloids
aleafia-health

Request Info

Enquire now

Request Info